- Home
- SPHL vs ALBT Comparison
SPHL vs ALBT Comparison
Compare SPHL & ALBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPHL
- ALBT
- Stock Information
- Founded
- SPHL 2002
- ALBT 2014
- Country
- SPHL Singapore
- ALBT United States
- Employees
- SPHL N/A
- ALBT N/A
- Industry
- SPHL Homebuilding
- ALBT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SPHL Consumer Discretionary
- ALBT Health Care
- Exchange
- SPHL Nasdaq
- ALBT Nasdaq
- Market Cap
- SPHL 7.3M
- ALBT 7.9M
- IPO Year
- SPHL 2024
- ALBT N/A
- Fundamental
- Price
- SPHL $0.44
- ALBT $4.90
- Analyst Decision
- SPHL
- ALBT
- Analyst Count
- SPHL 0
- ALBT 0
- Target Price
- SPHL N/A
- ALBT N/A
- AVG Volume (30 Days)
- SPHL 1.4M
- ALBT 99.4K
- Earning Date
- SPHL 02-21-2025
- ALBT 04-14-2025
- Dividend Yield
- SPHL N/A
- ALBT N/A
- EPS Growth
- SPHL 413.11
- ALBT N/A
- EPS
- SPHL 0.09
- ALBT N/A
- Revenue
- SPHL $11,020,429.00
- ALBT N/A
- Revenue This Year
- SPHL N/A
- ALBT N/A
- Revenue Next Year
- SPHL N/A
- ALBT N/A
- P/E Ratio
- SPHL $5.62
- ALBT N/A
- Revenue Growth
- SPHL 112.84
- ALBT N/A
- 52 Week Low
- SPHL $0.42
- ALBT $2.11
- 52 Week High
- SPHL $7.80
- ALBT $21.60
- Technical
- Relative Strength Index (RSI)
- SPHL N/A
- ALBT 43.81
- Support Level
- SPHL N/A
- ALBT $5.18
- Resistance Level
- SPHL N/A
- ALBT $7.89
- Average True Range (ATR)
- SPHL 0.00
- ALBT 0.64
- MACD
- SPHL 0.00
- ALBT -0.20
- Stochastic Oscillator
- SPHL 0.00
- ALBT 12.48
About SPHL Springview Holdings Ltd Class A Ordinary Shares
Springview Holdings Ltd is a company that conducts its operations through its indirect wholly-owned subsidiary which designs and constructs residential and commercial buildings in Singapore. It also provides four main types of works which includes new construction, reconstruction, Additions and Alterations (A&A), and other general contracting services such as renovation and design consultation.
About ALBT Avalon GloboCare Corp.
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment which is the key revenue driver; medical-related consulting services segment. It focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.